1. Ziopharm Oncology’s Controlled IL-12 Platform Receives EMA’s COMP Positive Recommendation for Orphan Drug Designation to Treat Glioma

Published: Aug 08, 2019 | Tags: COMP, Controlled, IL-12, EMA, Glioma, Orphan Drug Designation Platform, Positive, Receives, Recommendation, Treat, Ziopharm Oncology

2. Eli Lilly Reports the Availability of Verzenio (abemaciclib) for Metastatic Breast Cancer in Canada

Published: Aug 08, 2019 | Tags: Abemaciclib, Availability, Canada, Eli Lilly, Metastatic, Breast, Cancer Reports, Verzenio   

3. AstraZeneca Reports Updated Positive Results of Tagrisso (osimertinib) in P-III FLAURA Study for 1L EGFR-Mutated Non-Small Cell Lung Cancer

Published: Aug 09, 2019 | Tags: 1L, AstraZeneca, EGFR, FLAURA, Mutated, Non-Small Cell Lung Cancer, osimertinib, P-III, Positive, Results, Reports, Study, Tagrisso, Updated

4. Takeda Reports Submission of NDA to MHLW for Vedolizumab SC to Treat Moderately to Severely Active Ulcerative Colitis in Japan

Published: Aug 08, 2019 | Tags: Active, Japan, MHLW, Moderately, NDA, Reports, SC, Severely, Submission, Takeda, Treat, Ulcerative Colitis, Vedolizumab

5. Eli Lilly with Evidation Health and Apple Report Results of Digital Alzheimer’s Study

Published: Aug 07, 2019 | Tags: Alzheimer, Study, Apple, Digital, Eli Lilly, Evidation, Health, Report, Result

6. Bayer to Acquire BlueRock Therapeutics for its Cell Therapies

Published: Aug 08, 2019 | Tags: Acquire, Bayer, BlueRock Therapeutics, Cell Therapies, CELL+GENE, platform, iPSC technology, Versant Ventures

7.Gilead Sciences Receives the US FDA Advisory Committee’s Recommendation on Approval of Descovy for PrEP  

Published: Aug 08, 2019 | Tags: Advisory, Committee, approval, Descovy, Gilead Sciences, PrEP, Receives, Recommendation, the US FDA

8. Myriad to File sPMA to the US FDA of BRACAnalysis CDx as a Companion Diagnostic for Lynparza (olaparib) to Treat Metastatic Castrate-Resistant Prostate Cancer in Men

Published: Aug 07, 2019 | Tags: olaparib, BRACAnalysis CDx, Companion, Diagnostic, File, Lynparza, Men, Metastatic Castrate-Resistant Prostate Cancer, Myriad, sPMA, Treat, US FDA

9. Mitsubishi Tanabe’s Edaravone Receives NMPA’s Approval for Amyotrophic Lateral Sclerosis (ALS)

Published: Aug 08, 2019 | Tags: ALS, Amyotrophic Lateral Sclerosis, Approval, Edaravone, Mitsubishi Tanabe, NMPA, Receives

10. Akcea Therapeutics and Ionis Pharmaceutical Launch Waylivra (volanesorsen) for Familial Chylomicronemia Syndrome in EU

Published: Aug 08, 2019 | Tags: Akcea Therapeutics, EU, Familial Chylomicronemia Syndrome, Ionis Pharmaceutical, Launch, Volanesorsen, Waylivra

11. Stoke Therapeutics’ STK-001 Receives FDA’s Orphan Drug Designation for Dravet Syndrome

Published: Aug 06, 2019 | Tags: Dravet Syndrome, FDA, Orphan Drug Designation, Receives, Stk-001, Stoke Therapeutics

12. Aevi Genomic Medicine Signs an Option and License Agreement with AstraZeneca for its MEDI2338

Published: Aug 06, 2019 | Tags: Aevi Genomic, Medicine, Agreement, Astrazeneca, License, Medi2338, Option, Signs

13. Newsoara Biopharma Signs a Licensing Agreement with Zenith Epigenetics for its ZEN-3694

Published: Aug 06, 2019 | Tags: BioPharma, Licensing, Agreement, Newsoara, Signs, ZEN-3694, Zenith Epigenetics

14. NIH Launches LUCA Biologics to Develop Live Biotherapeutics for Women’s Health

Published: Aug 06, 2019 | Tags: NIH, Develop, Launches, Live Biotherapeutics, LUCA Biologics, Women’s Health

15. ADC Therapeutics and Sophia Genetics Collaborate to Identify Biomarkers in Clinical Study

Published: Aug 06, 2019 | Tags: ADC Therapeutics, Biomarkers, Clinical Study, Collaborate, Sophia Genetics

16. AstraZeneca and MSD’s Report Results of Lynparza in P-III PROfound Study for Metastatic Castration-Resistant Prostate Cancer with Homologous Recombination Repair Gene Mutation

Published: Aug 07, 2019 | Tags: AstraZeneca, Homologous Recombination Repair Gene Mutation, Lynparza, Metastatic Castration-Resistant Prostate Cancer, MSD P-III, PROfound, Reports, Results, Study

17. Spring Bank Signs a Research Agreement with the University of Texas Southwestern Medical School to Evaluate STING Antagonist Compounds

Published: Aug 07, 2019 | Tags: Compounds, Evaluate, Research, Agreement, Signs, Spring Bank, STING Antagonist University, Texas, Southwestern Medical School

18. Allergan Reports the Acceptance of EMA’s MAA for Abicipar to Treat Neovascular Age-Related Macular Degeneration

Published: Aug 06, 2019 | Tags: Abicipar, Acceptance,, Allergan, EMA, MAA, Neovascular Age-Related Macular Degeneration, Reports

19. Astellas Initiates P-III BRIGHT SKY Clinical Program for Fezolinetant in Postmenopausal Women with Vasomotor Symptoms

Published: Aug 06, 2019 | Tags: Astellas, BRIGHT SKY, Clinical, Program, Fezolinetant, Initiates, P-III, Postmenopausal Vasomotor Symptoms, Women

20. GSK and Sabin Signs an Exclusive Agreement to Advance the Development of Ebola and Marburg Vaccines

Published: Aug 06, 2019 | Tags: Advance, Agreement, Development, Ebola, Exclusive, GSK, Marburg, Sabin, Signs, Vaccines

21. Innovent and Shenogen Enter into a Collaboration to Evaluate the Combination of Tyvyt (sintilimab injection) + SNG1005 for Advanced Cancer

Published: Aug 06, 2019 | Tags: Advanced, Cancer, Collaboration, combination, Enter, Evaluate, Innovent, Shenogen, Sintilimab, Injection, SNG1005, Tyvyt

22. AstraZeneca and MSD’s Report Results of Lynparza in P-III PROfound Study for Metastatic Castration-Resistant Prostate Cancer with Homologous Recombination Repair Gene Mutation

Published: Aug 07, 2019 | Tags: Astrazeneca, Homologous, Recombination, Repair, Gene, Mutation, Lynparza, Metastatic, Castration-Resistant Prostate Cancer, MSD, P-III, Profound, Reports, Results, Study 

23. MannKind Enter into an Agreement with One Drop to Combine Bluetooth-Connected Inhaler with Dose Detection into the One Drop Platform

Published: Aug 05, 2019 | Tags: Agreement, Bluetooth-Connected, Inhaler, Combine, Dose, Detection, Enter, MannKind, One Drop ,One Drop Platform

24. LifeOmic Launches AI-Based LIFE Extend App to Expand Healthcare and Enable People to Adopt Five Health Pillars

Published: Aug 05, 2019 | Tags: Adopt, AI, Enabling, Five Health, Pillars, Launches, LIFE, Extend, App, LifeOmic, People

25. Sanofi and Regeneron’s Dupixent Receives European Commission Approval for Moderate-To-Severe Atopic Dermatitis in Adolescents

Published: Aug 06, 2019 | Tags: Adolescents, Approval, Atopic Dermatitis, Dupixent, European Commission, Moderate, Receives, Sanofi, Severe

26. Eli Lilly Reports Results of Emgality (galcanezumab-gnlm) in P-III CONQUER Study for Chronic and Episodic Migraine

Published: Aug 05, 2019 | Tags: (galcanezumab-gnlm), Chronic, CONQUER, Eli Lilly, Emgality, Episodic, Migraine, P-III, Reports, Results, Study

27. NUST MISIS Laboratory Develops an Ultrasound Tomography System for the Diagnosis of Cancer

Published: Aug 05, 2019 | Tags: Develops, Diagnosis, Cancer, NUST MISIS Laboratory, Ultrasound, Tomography System

28. Pfizer Reports Results of Rivipansel in P-III RESET Study for Sickle Cell Disease with Vaso-Occlusive Crisis

Published: Aug 02, 2019 | Tags: P-III, Pfizer, reports, RESET, results, Rivipansel, Sickle Cell Disease, study, Vaso-Occlusive Crisis

29. AstraZeneca Reports Label Update with Positive Cardiovascular Outcomes and Renal Data for Forxiga (dapagliflozin) in EU

Published: Aug 05, 2019 | Tags: AstraZeneca, Cardiovascular, Outcomes, Dapagliflozin, EU, Forxiga, Label, Positive, Renal Data, Reports, Update

30. Takeda Signs an Exclusive Multi-Target Research Agreement with Sosei Heptares to Develop and Commercialize Therapies Modulating GPCR

Published: Aug 05, 2019 | Tags: Agreement, Commercialize, Develop, Exclusive, GPCR, Modulating, Multi-Target, Research, Signs, Sosei, Heptares Takeda, Therapies

31. Roche Reports Results of Tecentriq in P-III IMvigor130 Study for Previously Untreated Advanced Bladder Cancer

Published: Aug 05, 2019 | Tags: Advanced, Bladder Cancer, IMvigor130, P-III, Previously, Report, Results, Roche, Study, Tecentriq, Untreated

32. Daiichi Sankyo’s Turalio (pexidartinib) Receives the US FDA’s Approval for the Symptomatic Tenosynovial Giant Cell Tumor